| (210) | Number of the EPO application | 16183261 |
| (220) | Filing date of the EPO application | 2016.08.08 |
| (80) | EPO patent specification publication (B) | EPB nr. 15/2021, 2021.04.14 |
| (110) | EPO patent number | 3128005 |
| (21) | Number of the application | e 2017 0079 |
| (71) | Name(s) of applicant(s), code of the country | ALX Oncology Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | DEMING Laura, US;
GOODMAN Corey, US;
PONS Jaume, US;
SIM Bang Janet, US;
VRLJIC Marija, US; |
| (73) | Name(s) of owner(s), code of the country | ALX Oncology Inc., US; |
| (54) | Title of the invention | Sirp-alpha variant constructs and uses thereof |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 14/705 (2006.01.01); C12N 15/62 (2006.01.01); A61K 38/17 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.01.31 |
| (30) | Priority | 201562202772 P, 2015.08.07, US; 201562202775 P, 2015.08.07, US; 201562202779 P, 2015.08.07, US; 104125902, 2015.08.10, TW; 201514971931, 2015.12.16, US |